Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD. Strassman AM, Melo-Carrillo A, Houle TT, Adams A, et al. Cephalalgia 2022;42:933-943.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Strassman AM, Melo-Carrillo A, Houle TT, Adams A, et al. Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD. Cephalalgia 2022;42:933-943.
PMID: 35332801